The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Uridine-5'-diphosphogalactose derivative ID: ALA2368691
PubChem CID: 73349946
Max Phase: Preclinical
Molecular Formula: C26H33N3O16P2
Molecular Weight: 705.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@@H](CNCc4cccc5ccccc45)[C@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1
Standard InChI: InChI=1S/C26H33N3O16P2/c30-18-8-9-29(26(36)28-18)24-22(34)20(32)17(42-24)12-41-46(37,38)45-47(39,40)44-25-23(35)21(33)19(31)16(43-25)11-27-10-14-6-3-5-13-4-1-2-7-15(13)14/h1-9,16-17,19-25,27,31-35H,10-12H2,(H,37,38)(H,39,40)(H,28,30,36)/t16-,17+,19-,20+,21-,22+,23-,24+,25+/m0/s1
Standard InChI Key: LLNDZYDGHYVOBO-QIUAJBRQSA-N
Molfile:
RDKit 2D
47 51 0 0 0 0 0 0 0 0999 V2000
4.5869 0.0713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1019 -0.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4073 -0.0149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8329 -6.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1184 -5.1656 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
5.8923 0.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2769 -0.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3569 -1.3807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1184 -6.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -3.9281 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -4.7531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8329 -5.5781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1184 -7.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2513 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5473 -6.8156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6894 -1.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0220 -1.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8329 -8.0531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7362 1.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5473 -7.6406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5567 1.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6894 -2.6906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7429 -0.7686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -3.1031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7059 -5.8801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5789 -3.9281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6907 -10.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0416 2.0737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5309 -4.4512 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7920 0.0713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9763 -10.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2289 -3.9281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -6.4031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4039 -8.0531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2618 -8.8781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2374 -1.6357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8329 -8.8781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6907 -11.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2618 -8.0531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9763 -9.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2618 -11.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2618 -10.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4052 -10.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9763 -11.7656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4052 -11.7656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1197 -10.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1197 -11.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
3 1 1 0
4 12 1 1
5 11 1 0
6 3 1 0
7 2 1 0
8 2 1 0
9 4 1 0
10 24 1 0
11 10 1 0
12 5 1 0
13 9 1 0
14 1 1 0
15 4 1 0
16 8 1 0
17 7 1 0
18 20 1 0
19 14 2 0
20 15 1 0
21 19 1 0
16 22 1 6
23 3 2 0
24 22 1 0
25 5 2 0
26 10 2 0
27 31 1 0
28 21 2 0
29 5 1 0
7 30 1 1
31 40 1 0
32 10 1 0
9 33 1 6
13 34 1 6
35 39 1 0
17 36 1 1
18 37 1 6
38 27 2 0
20 39 1 1
40 35 1 0
41 42 1 0
42 31 2 0
43 27 1 0
44 41 2 0
45 38 1 0
46 43 2 0
47 46 1 0
6 21 1 0
16 17 1 0
13 18 1 0
38 44 1 0
45 47 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 705.50Molecular Weight (Monoisotopic): 705.1336AlogP: -1.84#Rotatable Bonds: 12Polar Surface Area: 288.79Molecular Species: ACIDHBA: 16HBD: 9#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 9#RO5 Violations (Lipinski): 3CX Acidic pKa: 1.73CX Basic pKa: 8.47CX LogP: -3.38CX LogD: -5.58Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.09Np Likeness Score: 0.76
References 1. Takaya K, Nagahori N, Kurogochi M, Furuike T, Miura N, Monde K, Lee YC, Nishimura S.. (2005) Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase., 48 (19): [PMID:16162007 ] [10.1021/jm0504297 ]